Healthcare in a digital age
Position Paper
17 Jul 2022
Healthcare

The European Commission has presented a regulation to set up a European Health Data Space (EHDS). The Regulation sets out rules, common standards and practices, infrastructures and a governance framework that is key to the European Health Union.

For it to be successful, it is crucial that the EHDS ensures legal certainty and flexibility, and that it establishes open, transparent and structured engagement with all stakeholders. Moreover, the Commission must work towards fully linked EHR systems and sectoral standards for the collection and integration of patient-led data, while leveraging existing global and European Union standards and certifications. This includes taking the appropriate measures that ensure the interoperability of legal and operational requirements across organisational and geographical borders. Furthermore, international data flows for research and development purposes must be maintained, as it is key for global public health. For this, the Commission should limit hindrances on international data flows with third countries that could limit drug discovery and development.

Related items

Position Paper
11 Nov 2025

Advancing short-term improvements to the EU Medical Devices and In Vitro Diagnostic Regulations

The Medical Devices and In Vitro Diagnostics Regulations (MDR/IVDR) have created unworkable complexity for the medical devices industry, with dire consequences for European patients. To address these challenges, Members of the European Parliament (MEPs) or political groups can help address the unintended consequences of the current framework by tabling a Parliamentary Question that urges the European Commission to introduce targeted relief measures in parallel to a comprehensive revision of the MDR and IVDR. This would support the European Commission to implement short-term relief measures, in addition to the MDR/IVDR revision, that bolster efficiency, mitigate administrative bottlenecks and increase predictability in the regulatory processes. This would have an immediate impact on patient access and boost Europe’s innovation.

Healthcare
Read more
Read more about Advancing short-term improvements to the EU Medical Devices and In Vitro Diagnostic Regulations
Position Paper
7 Jul 2025

Critical Medicines Act: securing resilient and diversified supply chains for continuous access

The proposed Critical Medicines Act (CMA) offers a pivotal opportunity to strengthen the EU’s pharmaceutical resilience. By embracing global supply chain diversification, open trade and strategic international cooperation, the EU can reinforce access to essential medicines while preserving its competitiveness. However, to succeed, the CMA must steer clear of protectionist approaches that risk undermining the internal market and disrupting supply. Instead, it should promote pragmatic, market-driven solutions with strong industry involvement. Read our full position to explore how the EU can foster a stable, secure and innovation-friendly environment for medicines.

Healthcare
Read more
Read more about Critical Medicines Act: securing resilient and diversified supply chains for continuous access
Position Paper
25 May 2025

Consultation response: Revision of the Medical Devices and In Vitro Diagnostic Medical Devices Regulations

Healthcare
Read more
Read more about Consultation response: Revision of the Medical Devices and In Vitro Diagnostic Medical Devices Regulations